1. The EUROclass trial: Defining subgroups in common variable immunodeficiency
- Author
-
Wehr, C. (Claudia), Kivioja, T. (Teemu), Schmitt, C. (Christian), Ferry, B. (Berne), Witte, T. (Torsten), Eren, E. (Efrem), Vlkova, M. (Marcela), Hernandez, M. (Manuel), Detkova, D. (Drahomira), Bos, P.R. (Philip), Poerksen, G. (Gonke), Bernuth, H. (Horst) von, Baumann, U. (Ulrich), Goldacker, S. (Sigune), Gutenberger, S. (Sylvia), Schlesier, M. (Michael), Bergeron-Van der Cruyssen, F. (Florence), Le Garff, M. (Magali), Debré, P. (Patrice), Jacobs, R. (Roland), Jones, J. (John), Bateman, E. (Elizabeth), Litzman, J. (Jiri), Hagen, P.M. (Martin) van, Plebani, A. (Alessandro), Schmidt, R. (Reinhold), Thon, V. (Vojtech), Quinti, I. (Isabella), Espanol, T. (Teresa), Webster, A.D. (David), Chapel, H. (Helen), Vihinen, M. (Mauno), Oksenhendler, E. (Eric), Peter, H.H., Warnatz, K. (Klaus), Wehr, C. (Claudia), Kivioja, T. (Teemu), Schmitt, C. (Christian), Ferry, B. (Berne), Witte, T. (Torsten), Eren, E. (Efrem), Vlkova, M. (Marcela), Hernandez, M. (Manuel), Detkova, D. (Drahomira), Bos, P.R. (Philip), Poerksen, G. (Gonke), Bernuth, H. (Horst) von, Baumann, U. (Ulrich), Goldacker, S. (Sigune), Gutenberger, S. (Sylvia), Schlesier, M. (Michael), Bergeron-Van der Cruyssen, F. (Florence), Le Garff, M. (Magali), Debré, P. (Patrice), Jacobs, R. (Roland), Jones, J. (John), Bateman, E. (Elizabeth), Litzman, J. (Jiri), Hagen, P.M. (Martin) van, Plebani, A. (Alessandro), Schmidt, R. (Reinhold), Thon, V. (Vojtech), Quinti, I. (Isabella), Espanol, T. (Teresa), Webster, A.D. (David), Chapel, H. (Helen), Vihinen, M. (Mauno), Oksenhendler, E. (Eric), Peter, H.H., and Warnatz, K. (Klaus)
- Abstract
The heterogeneity of common variable immunodeficiency (CVID) calls for a classification addressing pathogenic mechanisms as well as clinical relevance. This European multicenter trial was initiated to develop a consensus of 2 existing classification schemes based on flowcytometric B-cell phenotyping and the clinical course. The clinical evaluation of 303 patients with the established diagnosis of CVID demonstrated a significant coincidence of granulomatous disease, autoimmune cytopenia, and splenomegaly. Phenotyping of B-cell subpopulations confirmed a severe reduction of switched memory B cells in most of the patients that was associated with a higher risk for splenomegaly and granulomatous disease. An expansion of CD21lowB cells marked patients with splenomegaly. Lymphadenopathy was significantly linked with transitional B-cell expansion. Based on these findings and pathogenic consideration of B-cell differentiation, we suggest an improved classification for CVID (EUROclass), separating patients with nearly absent B cells (less than 1%), severely reduced switched memory B cells (less than 2%), and expansion of transitional (more th
- Published
- 2008
- Full Text
- View/download PDF